Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,019 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Miyazaki K, Sakai R, Iwaki N, Yamamoto G, Murayama K, Nishikori M, Sunami K, Yoshida I, Yano H, Takahashi N, Okamoto A, Munemoto S, Sawazaki A, Suehiro Y, Fukuhara N, Wake A, Arai A, Masaki Y, Toyama K, Yokoyama A, Tsunemine H, Hasegawa Y, Matsumoto K, Yamada T, Nishimura Y, Tamaru S, Asano N, Miyawaki K, Izutsu K, Kinoshita T, Suzuki R, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: nishimura y. Cancer Sci. 2023 Jun;114(6):2689-2691. doi: 10.1111/cas.15784. Epub 2023 Mar 16. Cancer Sci. 2023. PMID: 36929591 Free PMC article. Clinical Trial. No abstract available.
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study.
Miyazaki K, Asano N, Yamada T, Miyawaki K, Sakai R, Igarashi T, Nishikori M, Ohata K, Sunami K, Yoshida I, Yamamoto G, Takahashi N, Okamoto M, Yano H, Nishimura Y, Tamaru S, Nishikawa M, Izutsu K, Kinoshita T, Suzumiya J, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: nishimura y. Haematologica. 2020 Sep 1;105(9):2308-2315. doi: 10.3324/haematol.2019.231076. Haematologica. 2020. PMID: 33054055 Free PMC article. Clinical Trial.
Relationship between CYP2C19 loss-of-function polymorphism and platelet reactivities with clopidogrel treatment in Japanese patients undergoing coronary stent implantation.
Nakata T, Miyahara M, Nakatani K, Wada H, Tanigawa T, Komada F, Hoshino K, Aoki T, Nishimura Y, Tamaru S, Ito M, Nishikawa M; McLordd Group. Nakata T, et al. Among authors: nishimura y. Circ J. 2013;77(6):1436-44. doi: 10.1253/circj.cj-12-1095. Epub 2013 Mar 8. Circ J. 2013. PMID: 23470885 Free article. Clinical Trial.
TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial.
Umekawa T, Maki S, Kubo M, Tanaka H, Nii M, Tanaka K, Osato K, Kamimoto Y, Tamaru S, Ogura T, Nishimura Y, Kodera M, Minamide C, Nishikawa M, Endoh M, Kimura T, Kotani T, Nakamura M, Sekizawa A, Ikeda T; TADAFER study group. Umekawa T, et al. Among authors: nishimura y. BMJ Open. 2018 Oct 30;8(10):e020948. doi: 10.1136/bmjopen-2017-020948. BMJ Open. 2018. PMID: 30381311 Free PMC article.
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants for Japanese Patients With Venous Thromboembolism　- The Primary Results From the KUROSIO Study.
Yamada N, Tamaru S, Umetsu M, Tsujita K, Nakamura M, Watanabe A, Yuzaki M, Nishimura Y, Ogura T, Yamamoto T, Satokawa H, Obayashi T, Nakamura M; KUROSIO Study Investigators. Yamada N, et al. Among authors: nishimura y. Circ J. 2024 Sep 25;88(10):1672-1678. doi: 10.1253/circj.CJ-23-0954. Epub 2024 May 28. Circ J. 2024. PMID: 38811209 Free article.
Exploratory rivaroxaban trial for isolated calf deep vein thrombosis with a risk factor of thrombosis extension: an open-label, multicenter, randomized controlled trial.
Ogihara Y, Yamada N, Izumi D, Sato Y, Sato T, Nakaya H, Mori T, Ota S, Makino M, Ogura T, Tamaru S, Nishimura Y, Tanigawa T, Kasai A, Nishikawa M, Dohi K; ISE CALF DVT Study Investigators. Ogihara Y, et al. Among authors: nishimura y. Res Pract Thromb Haemost. 2024 Jul 14;8(5):102515. doi: 10.1016/j.rpth.2024.102515. eCollection 2024 Jul. Res Pract Thromb Haemost. 2024. PMID: 39188889 Free PMC article.
Effect of combination therapy of ezetimibe and rosuvastatin on regression of coronary atherosclerosis in patients with coronary artery disease.
Masuda J, Tanigawa T, Yamada T, Nishimura Y, Sasou T, Nakata T, Sawai T, Fujimoto N, Dohi K, Miyahara M, Nishikawa M, Nakamura M, Ito M. Masuda J, et al. Among authors: nishimura y. Int Heart J. 2015 May 13;56(3):278-85. doi: 10.1536/ihj.14-311. Epub 2015 Apr 23. Int Heart J. 2015. PMID: 25902885 Free article. Clinical Trial.
Antialbuminuric effect of eplerenone in comparison to thiazide diuretics in patients with hypertension.
Sawai T, Dohi K, Fujimoto N, Okubo S, Isaka N, Ichikawa T, Makino K, Okamoto S, Koyabu S, Kitamura T, Ogura T, Yamada T, Tamaru S, Nishikawa M, Nakamura M, Ito M; OWASE Study Investigators. Sawai T, et al. J Clin Hypertens (Greenwich). 2017 Oct;19(10):990-998. doi: 10.1111/jch.13054. Epub 2017 Aug 28. J Clin Hypertens (Greenwich). 2017. PMID: 28849629 Free PMC article. Clinical Trial.
4,019 results